Skip to main content
OpenTrials
Completed

NCT Number: NCT05033639

Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis

Prematurity is still one of the primary causes of death in children under 5. 1-2. According to the WHO, 60% of all preterm births occur in Asia, with the Philippines accounting for around 348,900 every year. 3. Necrotizing enterocolitis is one of the fatal complications (NEC) 3, 4. Preterm newborns weighing 1500 grams or less are considered high risk. 5-6.

Melatonin is one chemical that may help prevent NEC. Melatonin is an endogenous indolamine derived from serotonin. It is a ubiquitous molecule that is crucial to the body's physiologic function. Melatonin, also known as N-acetyl-5-methoxytryptamine, is an immunomodulator, antioxidant, anti-inflammatory, and free radical scavenger7-10.

It is a naturally occurring chemical that is simply replenished. With this in mind, the researcher wants to see if providing high dose melatonin to premature babies can prevent NEC.

Completed

Looking for future studies?

Notify Me

Key information

Age range

28 week–36 week

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Ilocos Training and Regional Medical Center

San Fernando City, LA Union, 2500, Philippines

About this study

Prematurity remains as one of the leading causes of mortality among children less than 5 years old1-2. The World Health Organization that 60 percent of all preterm births around the world occurs in Asian countries and roughly 348,900 births occur each year in the Philippines3. One complication that contribute to the high mortality is necrotizing enterocolitis (NEC)1, 3-4. High risk population include preterm infants weighing 1500 grams and lower with inverse correlation to the patient's weight5-6.

One compound that could be used to prevent NEC is melatonin. Melatonin is an endogenously produced indolamine principally synthesized in the pineal gland from serotonin. It is described as a ubiquitous molecule which plays a vital role in the physiologic function of the body. Melatonin, also known as N-acetyl-5-methoxytryptamine which has a a) immunomodulator; b) free radical scavenger; c) prevention of oxidative stress and d) anti-inflammatory7-10.

It is a naturally occurring substance and it would just be supplemented to increase its levels. With all this in mind, the researcher would like to determine if giving high dose melatonin among preterm neonates could prevent NEC among high risk population.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 1. Newborn with a pediatric age of less than 37 weeks categorized very preterm (28 to 32 weeks) and late preterm (32 to 36weeks) by the World Health Organization weighing not more than 1500.
  • Preterm infants admitted at the Neonatal Intensive care unit of Ilocos Training Regional and Medical Center not more than 24 hours of age.
  • Preterm infants with orogastric tube in place. 4. Preterm infants with no other condition other than prematurity and respiratory distress syndrome.
  • Preterm infant with an Apgar score of more than 6 in the first minute of life.

Exclusion criteria

  • Preterm infants more than 1 day of life.
  • Preterm infants diagnosed with NEC
  • Preterm infants who is born to a mother of who considered as a minor (<18 years old) and is not married to the father of the unborn child.
  • Preterm infants that could not be fed through oral gastric tube due to a secondary problem.
  • Preterm infants with other comorbidities such as asphyxia, congenital anomalies, and other inherited disorders.
  • Meconium Stained Preterm infants

-

Treatment and study plan

Melatonin 6 MG

Drug

Melatonin is an endogenously produced indolamine principally synthesized in the pineal gland from serotonin. It is described as a ubiquitous molecule which plays a vital role in the physiologic function of the body. Melatonin, also known as N-acetyl-5-methoxytryptamine which has a a) immunomodulator; b) free radical scavenger; c) prevention of oxidative stress and d) anti-inflammatory7-10.

breast milk

Other

Naturally occurring milk from the mother of the infant.

Primary outcomes

  1. Number Of Preterm Infants Who Developed Necrotizing Enterocolits After Melatonin 6mg Tablet Prophylaxis

    Time frame: 5 MONTHS

    effectiveness of melatonin in preventing NEC among preterm infants with a birthweight of </ = 1500 kg at Ilocos Training and Regional Medical Center.

Secondary outcomes

  1. Incidence of Prematurity at Training and Regional Medical Center

    Time frame: 5 MONTHS

    Clinical Profiles Of Preterm Infants Born In Ilocos Training and Regional Medical Center

  2. Number of Patients Who Developed Abnormal Gas Pattern with Dilated Bowel Loops after Melatonin 6mg Tablet Prophylaxis

    Time frame: 5 MONTHS

    Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis.

  3. Number of Patients Who Developed Pneumatosis intestinalis after Melatonin 6mg Tablet Prophylaxis

    Time frame: 5 Months

    Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis.

  4. Number of Patients Who Developed Sentinel Loops after Melatonin 6mg Tablet Prophylaxis

    Time frame: 5 Months

    Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis.

  5. Number of Patients Who Developed Portal Venous Gas after Melatonin 6mg Tablet Prophylaxis

    Time frame: 5 Months

    Absence of Clinical And Radiologic Findings Diagnostic of Necrotizing Enterocolitis.

  6. Number Of Hospital Days Among Preterm Infants Admitted at Ilocos Training and Regional Medical Center

    Time frame: 5 Months

    Efficacy of Melatonin Oral Prophylaxis

  7. Number Of Days Before Oral FeedingAmong Preterm Infants Admitted at Ilocos Training and Regional Medical Center

    Time frame: 5 motnhs

    Efficacy of Melatonin Oral Prophylaxis

Sponsors and collaborators

Lead sponsor

Ilocos Training and Regional Medical Center

Other Gov

Collaborators

  • Vayu Global Foundation

Registry information

Official study title

Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis Among Preterm Infants In A Tertiary Level Hospital In The Philippines: A Randomized Control Trial

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Sep 5, 2021
Registry last updated
Jun 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.